Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in<i>in vitro</i>and<i>in vivo</i>pharmacokinetic studies employing Bcrp1−/−/Mdr1a/1b−/− (triple-knockout) and wild-type miceSerena Marchetti, Jan H.M. Schellens, Maria A.J. van Eijndhoven et al.|Molecular Cancer Therapeutics|2008Cited by 200
Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin AnaloguesFan Lin, Olaf van Tellingen, Serena Marchetti et al.|Clinical Cancer Research|2013Cited by 53
<i>In vitro</i> transport of gimatecan (7-<i>t</i>-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2Serena Marchetti, Jan H.M. Schellens, Roos L. Oostendorp et al.|Molecular Cancer Therapeutics|2007Cited by 35
Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPASerena Marchetti, Jan H.M. Schellens, Dick Pluim et al.|Investigational New Drugs|2013Cited by 26
“Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183”Serena Marchetti, Jan H.M. Schellens, Roberto Mazzanti et al.|Investigational New Drugs|2014Cited by 12